Bio-Rad Laboratories
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
28.5825.0517.34
Price/Sales ratio
3.082.972.80
Earnings per Share (EPS)
$10.01$11.42$16.5

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
39.1835.78190.8061.6819.196.274.545.29-3.45-14.79-3.856.27
Price/Sales ratio
1.602.002.593.273.024.776.817.714.463.534.993.02
Price/Book Value ratio
1.591.622.072.411.721.911.751.641.301.071.451.91
Price/Cash Flow ratio
12.7321.7324.7968.1324.2624.1130.1634.3364.4025.1531.7724.26
Price/Free Cash Flow ratio
25.4455.5671.68-629.5844.5030.7236.4242.07155.9843.2164.2944.50
Price/Earnings Growth ratio
2.961.66-2.490.160.090.010.030.450.010.180.020.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
54.18%55.54%55.02%54.96%53.46%54.37%56.48%56.13%55.93%53.58%56.04%53.46%
Operating Profit Margin
6.89%8.25%2.57%5.40%-4.74%9.93%16.14%16.74%17.22%13.69%16.95%-4.74%
Pretax Profit Margin
6.04%7.22%2.00%4.52%22.15%97.81%192.78%186.07%-167.87%-31.82%-168.14%97.81%
Net Profit Margin
4.08%5.60%1.35%5.31%15.76%76.07%149.83%145.56%-129.45%-23.85%-129.65%76.07%
Effective Tax Rate
32.46%22.45%32.32%-17.31%28.84%22.21%22.44%21.92%22.88%25.02%-34.07%22.21%
Return on Assets
2.65%3.04%0.73%2.68%6.44%21.95%29.40%23.93%-26.86%-5.18%-26.91%21.95%
Return On Equity
4.06%4.54%1.08%3.91%8.98%30.55%38.60%31.12%-37.72%-7.29%-39.09%30.55%
Return on Capital Employed
5.18%5.09%1.57%3.09%-2.10%3.23%3.33%2.86%3.73%3.10%3.67%-2.10%
Liquidity Ratios
Current Ratio
3.844.023.913.934.482.403.38N/AN/AN/A5.554.48
Quick Ratio
2.782.912.792.743.201.792.402.084.284.331.651.79
Cash ratio
0.921.030.960.760.960.721.040.690.760.770.760.76
Days of Sales Outstanding
63.3770.7565.7178.5462.5462.0060.1352.8964.4266.8164.4262.54
Days of Inventory outstanding
172.51199.30206.01223.18200.12191.73205.02162.93212.60229.76213.14200.12
Operating Cycle
235.88270.06271.72301.72262.67253.73265.15215.83277.03296.58229.02253.73
Days of Payables Outstanding
47.1049.7552.2350.7241.9337.0345.9440.4139.9142.5740.01K41.93
Cash Conversion Cycle
188.78220.30219.49251.00220.73216.69219.21175.41237.12254.00-39.89K216.69
Debt Ratios
Debt Ratio
0.130.110.110.100.070.050.000.000.080.090.280.07
Debt Equity Ratio
0.190.170.160.140.100.070.000.000.120.130.400.10
Long-term Debt to Capitalization
0.160.140.140.120.090.000.000.000.110.110.110.09
Total Debt to Capitalization
0.160.140.140.120.090.060.000.000.110.110.110.09
Interest Coverage Ratio
6.777.685.265.847.899.80-18.79N/AN/AN/A12.467.89
Cash Flow to Debt Ratio
0.620.420.490.230.641.06221.2859.660.160.310.361.06
Company Equity Multiplier
1.521.491.481.451.391.391.311.301.401.401.401.39
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.120.090.100.040.120.190.220.220.060.140.150.12
Free Cash Flow / Operating Cash Flow Ratio
0.500.390.34-0.100.540.780.820.810.410.580.490.78
Cash Flow Coverage Ratio
0.620.420.490.230.641.06221.2859.660.160.310.361.06
Short Term Coverage Ratio
1.03K624.86648.00247.34579.091.07442.561.34K418.16N/A948.19579.09
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A